Allergy Therapeutics achieve good sales growth in 2019
Allergy Therapeutics (LON:AGY), the fully integrated specialty pharmaceutical company specialising in allergy vaccines, today announced preliminary results for the year ended 30 June 2019. Highlights Financial Highlights · 8% revenue growth